secwatch.observer — SEC 8-K summary
======================================

Issuer:     RANGE IMPACT, INC. (RNGE)
CIK:        0001438943
Form:       8-K
Filed at:   2021-12-28T23:59:59+00:00
Accession:  0001493152-21-032599
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Malachite Innovations announces two USPTO patents granted for cannabinoid prodrugs and antimicrobials; new PCT filing
--------------------------------------------------------------------------------

- U.S. Patent granted for 'Cannabinoid Glycoside Prodrugs and Methods of Synthesis' covering 18 distinct cannabinoid glycosides for treating IBD and IBS.
- Second U.S. Patent granted for 'Antimicrobial Composition Comprising Cannabinoids' covering CBD/THC against C. diff, VRE, and S. pneumoniae.
- New PCT patent application filed for 'Continuous Enzymatic Perfusion Reactor System' to improve glycoside manufacturing; preserves rights in 153 countries.
- Patents based on 2016 and 2018 PCT filings, solidifying company's pioneer position in cannabinoid prodrugs without psychoactive effects.
- Subsidiary Graphium Biosciences holds patents; additional divisional applications are being pursued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221032599/0001493152-21-032599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221032599/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer